Endovascular Treatment for Acute Ischemic Stroke: Considerations from Recent Randomized Trials

Area of Science:

• Neurology
• Interventional Cardiology
• Vascular Surgery

Background:

• Intravenous recombinant tissue plasminogen activator therapy has limitations.
• Many patients are ineligible or do not respond to current treatments for acute ischemic stroke.

Purpose of the Study:

• To evaluate the effectiveness of endovascular treatment for acute ischemic stroke.
• To compare endovascular treatment with standard medical care.

Main Methods:

• The Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN) was a key randomized controlled trial.
• Analysis of clinical outcomes comparing endovascular intervention to standard medical treatment.

Main Results:

• Endovascular treatment demonstrated superior clinical outcomes compared to standard medical treatment.
• While endovascular treatment can lead to hemorrhagic complications, its overall efficacy is significant.
• Previous trials in 2013 did not show superiority, but MR CLEAN provides positive evidence.

Conclusions:

• Endovascular treatment is a highly effective intervention for acute ischemic stroke.
• Clinical evidence supports the use of mechanical devices for acute stroke intervention.
• Further randomized trials are expected to confirm the effectiveness of endovascular approaches.